Applications of Mass Spectrometry Imaging to Cancer

Erscheinungsjahr 2017
ISBN: 978-0-12-805249-5
Verlag: William Andrew Publishing

Buch, Englisch, 312 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 700 g

Applications of Mass Spectrometry Imaging to Cancer, the latest volume in the Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents original reviews on applications of mass spectrometry imaging to cancer.

Zielgruppe

Researchers and students in the basic and clinical sciences of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology.

Autoren/Hrsg.

Weitere Mitwirkende

Drake, Richard R

Mcdonnell, Liam

Fachgebiete

• Naturwissenschaften Chemie Analytische Chemie Massenspektrometrie, Spektroskopie, Spektrochemie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

1. The Importance of Histology and Pathology in Mass Spectrometry Imaging 2. Applications of Mass Spectrometry Imaging to Cancer 3. Assessing the Potential of Metal-Assisted Imaging Mass Spectrometry in Cancer Research 4. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues 5. In Situ Metabolomics in Cancer by Mass Spectrometry Imaging 6. Mass Spectrometry Imaging in Oncology Drug Discovery 7. MALDI IMS and Cancer Tissue Microarrays 8. Mass Spectrometry Imaging for the Investigation of Intratumor Heterogeneity 9. Ambient Mass Spectrometry in Cancer Research 10. Rapid Mass Spectrometry Imaging to Assess the Biochemical Profile of Pituitary Tissue for Potential Intraoperative Usage 11. Mass Spectrometry Imaging in Cancer Research: Future Perspectives

Über Autor(innen)

Drake, Richard R
Dr. Drake is a Professor in the Department of Cell and Molecular Pharmacology and Experimental Therapeutics at the Medical University of South Carolina and SmartState Endowed Chair in Proteomics. He is an experienced protein biochemist and glycobiologist, with particular expertise in tumor biology and biomarker discovery from clinical fluids and tissues related to urological cancers and other cancers. He obtained his Ph.D. in Biochemistry at the University of Kentucky with Boyd Haley, generating multiple nucleotide sugar photoaffinity analogs for use in the study of glycosyltransferases. More extensive glycobiology training was done in post-doctoral work with Alan Elbein, and he began his academic career in Dr. Elbein's department at the University of Arkansas for Medical Sciences. Currently, his research focus is on direct analysis of glycans and glycolipids in tissues using state-of-the-art MALDI mass spectrometry imaging approaches. Complementary glycopeptide mass spectrometry and metabolic labeling targeted approaches are being done to identify specific glycoproteins involved in the epithelial-to-mesenchymal transition.